P74 Giraud, F.; Guillon, R.; Logé, C.; Pagniez, F.; Picot, C.; Le Borgne, M.; Le Pape, P. Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents. Bioorg. Med. Chem. Lett., 2009, 19(2), 301-304

P75 Farard, J.; Logé, C.; Pfeiffer, B.; Lesur, M.; Duflos, M. A convenient synthesis of 5-arylamino-4H-pyran-4-ones using palladium-catalyzed amination. Tetrahedron Lett., 2009, 50(41), 5729-5732.

 

P76 Marchand, P.; Antoine, M.; Le Baut, G.; Czech, M.; Baasner, S.; Günther, E. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents. Bioorg. Med. Chem., 2009, 17(18), 6715-6727.

 

P77 Giraud, F.; Logé, C.; Pagniez, F.; Crépin, D.; Barres, S.; Picot, C.; Le Pape, P.; Le Borgne, M. Design, synthesis and evaluation of 3-(imidazol-1-ylmethyl)indoles as antileishmanial agents. Part II. J. Enz. Inh. Med. Chem., 2009, 24(5), 1067-1075.

 

P78 Carbonnelle, D.; Duflos, M.; Marchand, P.; Chauvet, C.; Petit, J-Y.; Lang, F. A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells. J. Pharmacol. Exp. Ther., 2009, 331(2), 710-716.

 

P79 Guillon, R.; Giraud, F.; Logé, C.; Le Borgne, M.; Picot, C.; Pagniez, F.; Le Pape, P. Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols. Bioorg. Med. Chem. Lett., 2009, 19(20), 5833-5836.


P80 Alvarez-Rueda, N.; Biron, M.; Le Pape, P. Infectivity of Leishmania mexicana Is Associated with Differential Expression of Protein Kinase C-Like Triggered during a Cell-Cell. PLoS ONE, 2009, 4(10), 1-9.


P81 Pineau, S.; Talarmin, J-P.; Morio, F.; Grossi, O.; Boutoille, D.; Léauté, F.; Le Pape, P.; Gay-Andrieu, F.; Miegeville, M.; Raffia, F.
Contribution de la biologie moléculaire et de l'antigénémie galactomannane aspergillaire au diagnostic de l'histoplasmose. Med. Mal. Infect., 2009, doi:10.1016/j.medmal.2009.10.005, sous presse.